RxDoctor Payments Data

Jamie Doucet, MD

Interventional Cardiology · Boulder, CONPI 1417994385

Payments from drug & device makers

$1,264in general payments, 2019–2025

Across 25 payments — averaging $50.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Heartflow, Inc.$552
  • Impulse Dynamics (USA) Inc.$146
  • Shockwave Medical, Inc$104
  • Amgen$104
  • Kiniksa Pharmaceuticals International, PLC$101
  • Boston Scientific$58
  • plus $199 from 7 others

What the payments were for

  • Food & beverage$1,264100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,264 in reported general payments places this provider in the 10th percentile of 111 interventional cardiology providers in Colorado.

See all interventional cardiology providers in Colorado

Medicare billing

Part B allowed, 2024
$209,521
Medicare patients
1,000
Services billed
2,773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban300$412,906
Repatha SureclickEvolocumab139$164,193
Praluent PenAlirocumab57$62,062
JardianceEmpagliflozin34$54,354
XareltoRivaroxaban33$31,300
Repatha SyringeEvolocumab13$19,064
Ezetimibe219$6,773
Rosuvastatin Calcium574$6,603
Propafenone Hcl ErPropafenone Hcl19$4,823
Atorvastatin Calcium317$3,210
Metoprolol Succinate208$2,505
Diltiazem 24hr Er (Cd)Diltiazem Hcl64$2,165
Dofetilide13$2,144
Irbesartan121$2,083
Niacin ErNiacin25$1,760

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Boulder

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →